Primary Image

Generic Background Image

Clinical Trial

An Exploration of Acute Intermittent Hypoxia as a tool to Enhance Neural Recovery in Stroke Survivors; a pilot safety study.

IRB Protocol Number STU00208610

Contact

Alexander Barry abarry@sralab.org

Atomized Content

Body

This study is complete and is no longer recruiting subjects.

Objective

This is a Phase I safety study. Our plan consists of dose-escalation exposures with continual assessment of hypoxic conditioning impact in individuals with chronic stroke. We plan to measure changes in arm strength and hand grip strength before AIH, and following each AIH exposure sequence. We will use a three-second maximum contraction, and calculate the mean of three grip strength estimates at each time epoch, with at least a 60 second rest periods between trials to prevent fatigue. We will test elbow flexion and extension strength, using a commercial dynamometer in a similar fashion.

Who Can Participate

Those who have experienced  A first time, unilateral, ischemic, hemispheric stroke, confirmed by magnetic resonance imaging (MRI); 6 months post stroke

Compensation

YES

Apply for this Trial

Your information will not be published.

All fields are required.

More Studies

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis (PREDICT)

This is a clinical trial of people who have pain due to knee osteoarthritis at Northwestern University Feinberg School of Medicine in collaboration with Shirley Ryan 小恩雅. The study will last for about 20 weeks. 180 qualified participants will be randomly assigned in a 1:1:1 ratio (60 participants per group) to one of three treatment groups: duloxetine, celecoxib or placebo. Participants will have an X-ray, knee MRI, brain MRI, blood draws, pain sensitivity testing and will be asked to fill out questionnaires. The purpose of this study is to predict which participants will respond to the treatment.

read more
view all

Latest Updates

view all